Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Ovarian Neoplasms × Methotrexate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1 Breast 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 76 Leukemia 58 Lymphoma 44 Leukemia, Myeloid, Acute 31 Burkitt Lymphoma 31 Myelodysplastic Syndromes 25 Lymphoma, Non-Hodgkin 23 Lymphoma, Mantle-Cell 23 Hodgkin Disease 23 Lymphoma, Large B-Cell, Diffuse 20 Leukemia, Lymphocytic, Chronic, B-Cell 20 Lymphoma, Follicular 18 Recurrence 17 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 17 Graft vs Host Disease 17 Lymphoma, B-Cell, Marginal Zone 13 Congenital Abnormalities 13 Multiple Myeloma 12 Leukemia, Myelomonocytic, Chronic 12 Lymphoma, Large-Cell, Immunoblastic 11 Leukemia, Myeloid, Chronic-Phase 11 Leukemia, Myeloid, Accelerated Phase 11 Breast Neoplasms 11 Myeloproliferative Disorders 10 Lymphoma, Large-Cell, Anaplastic 10 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 10 Hematologic Neoplasms 10 Blast Crisis 10 Primary Myelofibrosis 9 Osteosarcoma 9

Interventions

Paclitaxel 80 Carboplatin 76 Bevacizumab 53 Gemcitabine 29 pembrolizumab 27 liposomal doxorubicin 27 Topotecan 22 olaparib 19 Taxes 17 niraparib 15 Docetaxel 15 Immunoglobulin G 14 Disulfides 14 Cyclophosphamide 14 Cisplatin 11 durvalumab 10 Nivolumab 9 Doxorubicin 8 Albumin-Bound Paclitaxel 8 sargramostim 7 rucaparib 7 fludarabine phosphate 7 fludarabine 7 pazopanib 6 epacadostat 6 avelumab 6 Trabectedin 6 Magnetic Resonance Spectroscopy 6 Ipilimumab 6 Interleukin-2 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01432145 2019-07-09

6MP

University of Oxford

Phase 2 Completed

74 enrolled 13 charts

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡